Neuropsychological Tests

Alzheimer's disease and dementia are progressive neurological conditions impacting memory, cognitive abilities, and behavior. Alzheimer's, the most prevalent form of dementia, is characterized by the accumulation of beta-amyloid plaques and tau protein tangles in the brain, resulting in the gradual deterioration of neurons and brain tissue. Symptoms typically begin with mild memory impairment and worsen over time, significantly affecting daily functioning.

Neuropsychological assessments are pivotal in diagnosing Alzheimer's and dementia, evaluating various cognitive domains like memory, attention, language, and problem-solving skills. These tests provide critical insights into the extent and progression of cognitive decline, aiding clinicians in treatment planning and monitoring. They play a crucial role in distinguishing Alzheimer's from other forms of dementia and in tracking cognitive changes longitudinally. Early detection through these assessments facilitates timely interventions and support, enhancing patient care and management strategies for individuals and their families.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China
Tags

Submit your abstract Today

Whatsapp